Ireland
--:--IST
Starting soon Observational

Thyroid and Adrenal Disorders in ICU

NCT07245550 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2025-12-01
Last updated
2025-11-24

Condition(s) studied

Septic Shock

Investigational drug(s) / intervention(s)

Blood sampling

Blood sampling: Blood sampling for the hormones

Study summary

A dysregulated host response to infection results in organ failure and sepsis, a potentially fatal illness. Sepsis killed about 11 million people worldwide in 2017 and had a death rate close to 20 %

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion criteria * All Patients who match the diagnostic criteria for sepsis/septic shock as stated * admitted in ICU Exclusion Criteria: 1. Patients refuse to be enrolled in the study 2. Patients with previous endocrinal disorders. 3. Patients receiving corticosteroid or thyroid hormonal therapy. 4. Pregnancy or lactation. 5. Previous endocrinal gland surgery. 6. Individuals with pacing rhythms, bundle branch blocks (QRS interval \>120 ms),

Primary outcome measure(s)

  • serum Thyroid and adrenal hormones levels — 24 hours
    measurement of thyroid and adrenal hormones (TSH-FT3-FT4 - cortisol level ) will be measured by ELLISA technique in septic shock patients at ICU.

Trial sites (1)

FacilityCityRegionStatus
Radwa mahmoud Asyut Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07245550 on ClinicalTrials.gov ↗ ← All trials in Egypt